CellOrigin Unveils Two Novel Solid-Tumor Cell Therapy Candidates at ASCO 2026, Partners with Walvax for In Vivo CAR Clinical Trial

CellOrigin Unveils Two Novel Solid-Tumor Cell Therapy Candidates at ASCO 2026, Partners with Walvax for In Vivo CAR Clinical Trial

HANGZHOU, China, July 31, 2026 /PRNewswire/ -- CellOrigin, a biotechnology company focused on next-generation in vivo and in vitro cell therapy technologies, has announced two major progresses in both research and strategic partnership. At the 2026...

Shop-Vac Introduces a New Generation of Handheld Vacuums Designed for Real Life

Shop-Vac Introduces a New Generation of Handheld Vacuums Designed for Real Life

WILLIAMSPORT, Pa., June 20, 2026 /PRNewswire/ -- Some of life's best moments also happen to be the messiest. Stylish, Lightweight, and Always Ready for Life's Everyday Messes. Whether it's crumbs after a family road trip, pet hair on the couch, or...

menu
menu